GlassScriptPhysician profile
Joanna P Read
NPI 1477552198
$1,215.30
in general payments reported to CMS, 2019-2025
20 companies · $22.23 in 2025
The $22.23 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $771 · 2023: $331 · 2024: $91.11 · 2025: $22.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $444.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $199.26 | 2022-2024 | Enhertu |
| Celgene Corporation | $196.64 | 2022-2024 | Pomalyst, Reblozyl |
| Lilly USA, LLC | $163.96 | 2022 | |
| Novartis Pharmaceuticals Corporation | $111.34 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $109.17 | 2022-2023 | Keytruda, Welireg, Lynparza |
| Sanofi-Aventis U.S. LLC | $67.99 | 2022 | |
| Amgen INC. | $50.62 | 2022 | |
| Pfizer INC. | $49.41 | 2022-2023 | |
| Alexion Pharmaceuticals, INC. | $35.63 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $34.97 | 2022-2023 | |
| G1 Therapeutics, INC. | $33.90 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.40 | 2022 | |
| Seagen INC. | $27.22 | 2022 | |
| Beigene USA, INC. | $18.53 | 2022 | |
| Pharmacyclics LLC, An Abbvie Company | $16.10 | 2023 | Imbruvica |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Puma Biotechnology, INC. | $15.56 | 2024 | |
| Exelixis INC. | $15.55 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $14.85 | 2023 | Libtayo |
| Teleflex LLC | $13.47 | 2022 | |
| Incyte Corporation | $12.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanna Read listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.